Top Markets
#1 Status Status +19.34%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.51%
#3 GoPlus Security GoPlus Security +14.26%
#4 Ontology Gas Ontology Gas +12.27%
#5 DMT-NAT DMT-NAT +8.99%
#6 Nillion Nillion +7.04%
#7 Provenance Blockchain Provenance Blockchain +7.02%
#8 Janction Janction +6.49%
#9 Cap Cap +6.34%
#10 Bedrock Bedrock +5.75%
Coin of the day
Status Status
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
Rankning i aktier #33959
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Aktiekurs
$1.83
Senast synkroniserad: 2026-08-14
Marknadsvärde
$6.53M
Förändring (1 dag)
-1.61%
Förändring (1 år)
-85.57%
Land
US
Handel Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Kategori

Healthcare
Aktiekurshistorik för Cadrenal Therapeutics, Inc. Common Stock (CVKD)
Högsta slutkurs: $1.89 den 2026-08-01

Lägsta slutkurs: $46.78 den 2023-01-01
Aktiekurshistorik för Cadrenal Therapeutics, Inc. Common Stock från 2023 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -11.31%
2025 -35.19%
2024 69.00%
2023 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE